Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
This review aims to provide healthcare professionals with a thorough understanding of BPC-157 and TB-500, including their molecular characteristics, proposed mechanisms of action, clinical indications, current evidence for therapeutic efficacy, safety considerations, and the critical importance of cancer screening in patient selection protocols
Imadojemu S, Fiester A
PASI90 response: the new standard in therapeutic efficacy for psoriasis
Your provider can assess your individual vulnerability
Each vial contains: TB-500 10 mg BPC-157 10 mg Includes 1 3 ml vial of bacteriostatic water (for research use only) Product Information: Form: white/off-white lyophilized powder Total Peptide Content: 20 mg (10 mg each) Purity: 99 % (research grade) Blend: TB-500 / BPC-157 Supplied in: sterile 2 ml vial Storage: keep sealed in a cool, dry environment
A slow stream down the wall keeps the molecule intact
